Olympus launches second VC fund with $150m commitment
Olympus Corporation has committed $150m to a new venture capital (VC) fund, aiming to deploy the capital to promising medtech …
Post
-
-
Philips doubles down on image-guided therapy with SpectraWAVE acquisition
Philips has signed a deal to acquire enhanced vascular imaging (EVI) product developer SpectraWAVE, expanding the Dutch medtech giant’s minimally …
-
Vaxxas gains Australia’s TGA licence to manufacture HD microarray patch
Vaxxas has received a manufacturing licence from Australia’s Therapeutic Goods Administration (TGA) for its high-density microarray patch (HD-MAP) for clinical …
-
FDA approves P&F’s transcatheter bicaval valve system trial
The US Food and Drug Administration (FDA) has granted approval to P&F USA to begin the randomised, controlled TRICAV II …
-
FDA clears Bendit’s steerable vascular microcatheter
Israel-based Bendit Technologies’ steerable microcatheter has gained clearance from the US Food and Drug Administration (FDA), providing US clinicians with …
-
Subsense secures $10m to advance BCI R&D efforts
US-based Subsense has raised $10m, bringing the brain-computer interface (BCI) developer’s total funding to $27m since it emerged from stealth …
-
Vesalio secures FDA clearance for enVast clot retriever
The Food and Drug Administration (FDA) has granted 510(k) clearance for Vesalio’s enVast clot retriever, paving the way for its …
-
Guardant Health and Trial Library to expand access to US cancer trials
Guardant Health and AI technology firm Trial Library have formed a strategic partnership aimed at improving access to cancer clinical …
-
FDA clears Flow Neuroscience’s at-home depression treatment in US first
The US Food and Drug Administration (FDA) has cleared Flow Neuroscience’s at-home, non-drug depression treatment, making it the first device …
-
FDA greenlights Lumos Labs’ digital ADHD therapeutic
Lumos Labs has gained US Food and Drug Administration (FDA) clearance for LumosityRx, a prescription digital therapeutic (PDT) that aims …
-
Impulse Dynamics raises $158m to advance clinical and technology pipelines
Impulse Dynamics has secured over $158m in funding aimed at supporting its commercialisation efforts and progressing its clinical and technology …
-
First patient treated in Nitinotes’ trial of EndoZip system for ESG
Nitinotes has commenced its US investigational device exemption (IDE) Endoscopic Automated Sleeve Evaluation (EASE) clinical trial, with the first patient …
-
Medical Device Network Excellence Awards 2025: Penumbra
Penumbra’s launch of the Ruby® XL peripheral embolization coil system won the Innovation award in the Vascular Solutions category and …
-
FDA clears HeartBeam’s at-home arrhythmia assessment tool
HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis software, setting the arrhythmia …
-
Teleflex to sell trio of business lines in deals totalling over $2bn
Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two separate deals totalling over …
